Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2013 1
2015 3
2016 6
2017 5
2018 3
2019 3
2020 3
2021 5
2022 12
2023 13
2024 13
2025 10
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
Bhave MA, Quintanilha JCF, Tukachinsky H, Li G, Scott T, Ross JS, Pasquina L, Huang RSP, McArthur H, Levy MA, Graf RP, Kalinsky K. Bhave MA, et al. Among authors: graf rp. Breast Cancer Res Treat. 2024 Oct;207(3):599-609. doi: 10.1007/s10549-024-07376-w. Epub 2024 Jun 14. Breast Cancer Res Treat. 2024. PMID: 38872062 Free PMC article.
Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.
Richardson DL, Quintanilha JCF, Danziger N, Li G, Sokol E, Schrock AB, Ebot E, Bhardwaj N, Norris T, Afghahi A, Frachioni A, Washington C, Dockery L, Elvin J, Graf RP, Moore KN. Richardson DL, et al. Among authors: graf rp. Clin Cancer Res. 2024 Oct 15;30(20):4644-4653. doi: 10.1158/1078-0432.CCR-24-1225. Clin Cancer Res. 2024. PMID: 39078736 Free PMC article.
Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.
Gandara DR, Agarwal N, Gupta S, Klempner SJ, Andrews MC, Mahipal A, Subbiah V, Eskander RN, Carbone DP, Riess JW, Sammons S, Snider J, Bouzit L, Cho-Phan C, Price M, Li G, Quintanilha JCF, Huang RSP, Ross JS, Fabrizio D, Oxnard GR, Graf RP. Gandara DR, et al. Among authors: graf rp. J Immunother Cancer. 2025 Feb 6;13(2):e010311. doi: 10.1136/jitc-2024-010311. J Immunother Cancer. 2025. PMID: 39915003 Free PMC article.
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer.
Sweeney CJ, Petry R, Xu C, Childress M, He J, Fabrizio D, Gjoerup O, Morley S, Catlett T, Assaf ZJ, Yuen K, Wongchenko M, Shah K, Gupta P, Hegde P, Pasquina LW, Mariathasan S, Graf RP, Powles T. Sweeney CJ, et al. Among authors: graf rp. Clin Cancer Res. 2024 Sep 13;30(18):4115-4122. doi: 10.1158/1078-0432.CCR-24-1096. Clin Cancer Res. 2024. PMID: 38990098 Free PMC article. Clinical Trial.
FoundationOne CDx and FoundationOne Heme Detect Epstein-Barr Virus with High Sensitivity and Specificity.
Honecker J, Paffenholz D, Jungmann J, Wieland T, Kou AA, Yang SR, Vanderbilt CM, Shanmugam V, Montesion M, Graf RP, Albacker LA, Lin DI, Heilmann A, Lakis S, Hickman RA, Decker B, Robertson A, Ritterhouse LL, Mata DA. Honecker J, et al. Among authors: graf rp. J Mol Diagn. 2025 Oct;27(10):920-935. doi: 10.1016/j.jmoldx.2025.06.002. Epub 2025 Jul 23. J Mol Diagn. 2025. PMID: 40712992 Free PMC article.
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.
Sayegh N, Graf RP, Swami U, Ozay ZI, Hage Chehade C, Elvin JA, Lin D, Quintanilha JCF, Li G, Bryce AH, McKay RR, Ross JS, Zhang T, Agarwal N. Sayegh N, et al. Among authors: graf rp. Clin Cancer Res. 2026 Feb 17;32(4):801-812. doi: 10.1158/1078-0432.CCR-25-2750. Clin Cancer Res. 2026. PMID: 41342879 Free PMC article.
75 results